Skip to main content

PERSPECTIVE article

Front. Hum. Neurosci.
Sec. Brain Health and Clinical Neuroscience
Volume 19 - 2025 | doi: 10.3389/fnhum.2025.1504575
This article is part of the Research Topic Bipolar Disorder: Where are we now? Treatment Response, Neural Correlates and Personality View all articles

The Role of Blood-Brain Barrier Dysfunction in Cognitive Impairments in Bipolar Disorder -a Narrative Review

Provisionally accepted
Caitlin Millett Caitlin Millett 1,2,3,4*Faria Monir Faria Monir 1,3Pina Sanelli Pina Sanelli 1,2
  • 1 Northwell Health, New York, United States
  • 2 Feinstein Institute for Medical Research, New York, New York, United States
  • 3 Division of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, New York, United States
  • 4 Donald and Barbara Zucker School of Medicine, Hofstra University, Hempstead, New York, United States

The final, formatted version of the article will be published soon.

    Bipolar disorder (BD) is a chronic and debilitating mental illness affecting approximately 40 million people worldwide. Cognitive impairment is a core feature of BD, impacting daily functioning and persisting even during mood stability. Cognitive deficits are among the most reliable indicators of long-term functional outcomes in BD. Despite their significance, there are currently no widely available treatments targeting cognitive impairment in BD, largely due to our limited understanding of the underlying pathophysiology. A healthy blood-brain barrier (BBB) is essential for brain homeostasis, serving as a protective filter that restricts peripheral toxins, pathogens, and ions from entering the brain and disrupting neuronal function. Increased BBB permeability can allow harmful substances to infiltrate the brain, potentially leading to neuroinflammation, disrupted signaling, and damage to brain tissue, all of which may contribute to cognitive impairments in BD. Thus, BBB dysfunction could represent an upstream driver of cognitive impairment in BD, offering a potential target for disease-modifying interventions. This narrative review examined the evidence for the link between BBB permeability and cognitive deficits in BD. Our search yielded limited studies with mixed findings, highlighting the significant need for further research to explore this critical area and its potential for developing diseasemodifying treatments.

    Keywords: cognitive deficits, biomarkers, neurovascular permeability, Mood Disorders, mania

    Received: 02 Oct 2024; Accepted: 27 Jan 2025.

    Copyright: © 2025 Millett, Monir and Sanelli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Caitlin Millett, Northwell Health, New York, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.